Compare UiPath Inc (PATH) vs Philip Morris International Inc. (PM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UiPath Inc vs Philip Morris International Inc. — how do they compare? UiPath Inc trades at $13.45 (market cap $6.91B), while Philip Morris International Inc. trades at $200.5 (market cap $312.50B). The key difference: Philip Morris International Inc. is far larger — about 45.2× UiPath Inc's market cap, and Philip Morris International Inc. pays a 3.19% dividend while UiPath Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold UiPath Inc for 139 Days and Philip Morris International Inc. for 85 Days on average.
| PATH | PM | |
|---|---|---|
Market Cap | $6.91B | $312.50B |
Volume | 34,321,250 | 5,517,172 |
Sector | Technology | Consumer Staples |
52-Week High | $19.29 | $200.50 |
52-Week Low | $9.38 | $144.33 |
Typical Hold Time | 139 Days | 85 Days |
Enterprise Value | $5.70B | $355.62B |
Dividend Yield | — | 3.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
UiPath (PATH) trades at $13.48, up 3.14% today, showing technical bullish momentum despite mixed earnings results. The company demonstrates strong revenue growth from $892M in 2022 to $1.43B in 2025, with improving profit margins turning positive in 2026. Recent partnerships with Snowflake and BDO highlight expansion in AI orchestration capabilities, while analyst sentiment remains cautious with 67% hold ratings.
PATH offers growth potential through enterprise automation leadership and AI integration, but faces execution risks and competitive pressure. The stock trades below consensus price target of $15.13, representing 12% upside, though negative cash flow trends and valuation concerns warrant careful monitoring of quarterly execution against guidance.
Philip Morris International (PM) trades at $192.69, up 1.2% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 EPS beat expectations at $2.20 vs. $2.05, and revenue growth accelerated to $40.65B in 2025. The company's smoke-free products now drive 42% of revenue, with ZYN and IQOS expansions fueling optimism. Cash flow remains robust, with 2026 operating cash flow projected at $14.3B, supporting dividend growth.
Outlook is positive given earnings momentum and smoke-free transition, but high debt ($42.17B long-term) and regulatory risks persist. The consensus price target of $212.17 implies ~10% upside, though valuation multiples are elevated versus peers. Key risks include FX volatility and slower adoption of next-gen products.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UiPath Inc
UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →About Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →
